The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective.
about
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.Detection of ciprofloxacin-resistant Yersinia pestis by fluorogenic PCR using the LightCycler.Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States.Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacinEmergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.Resistance pattern of ciprofloxacin against different pathogens.Reconstructing rare soil microbial genomes using in situ enrichments and metagenomics.Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women.Linezolid alone or combined with rifampin against methicillin-resistant Staphylococcus aureus in experimental foreign-body infection.Comparison of the selection of antimicrobial resistance in fecal Escherichia coli during enrofloxacin administration with a local drug delivery system or with intramuscular injections in a swine model.Target site concentrations of ciprofloxacin after single intravenous and oral dosesIndirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.In vitro activity of the new quinolone WCK 771 against staphylococci.Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence.Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacinIn vitro activity of rifaximin against enteropathogens producing traveler's diarrheaDraft Genome Sequences of Two Drug-Resistant Isolates of Pseudomonas aeruginosa Obtained from Keratitis Patients in India.Synergistic effect of a novel focal hyperthermia on the efficacy of rifampin in staphylococcal experimental foreign-body infection.Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.In vitro antimicrobial susceptibility of 183 Pseudomonas aeruginosa strains isolated from dogs to selected antipseudomonal agents.Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts.PCR identification and automated ribotyping of Pseudomonas aeruginosa clinical isolates from intensive care patients.Quinolone-resistant clinical strains of Pseudomonas aeruginosa isolated from University Hospital in Tunisia.Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
P2860
Q30934642-A8F7078B-5DBB-4C1E-B0AB-AB0C7B3C81D8Q33807598-DFE48F16-9CD7-4C7D-9610-C811DB02041BQ33973670-AB4B70CE-7C30-4417-A086-DBEE5A4A5AABQ33980574-5554F709-99C5-4880-85DD-8F9FEA604223Q33981698-A2649267-FB63-4C08-BBCF-B6589745D610Q33983331-BEC4AE34-95AA-4F7E-B215-D937FD6CC702Q35323705-C310FD61-2983-48C6-B54E-F80FAC1E7ED6Q35557021-071FC60A-5756-4919-A0D8-246650652F36Q36080164-73258BF8-CE38-4C01-B19D-EE2EE29A6836Q36754301-C443ABCF-9845-49C2-8ECC-40B97CC7EDF8Q37115701-C731BDA6-7893-479A-8B95-F34064DF9647Q39656622-DA1FCA5E-0882-409D-9FCA-D88927E59883Q39671107-821D84F1-B30E-437A-9DB2-74FA35C1CFC8Q39884320-67F95ADB-281F-4603-8BC4-19A054F9740DQ39955054-E3ABF2A1-9519-4468-8089-E5A79D58D4D3Q40119937-234A473D-BDA7-4216-A1E7-AB4543EF1DD9Q42078632-7E4ABDCD-D171-4827-8BE8-A257B4F14657Q42730284-003EC01F-D20D-4746-860A-390D827C33A7Q43101882-FBEB0B89-34D6-4F98-89BA-81EB97D76C41Q43275288-0A22FA80-D2F6-4DBA-BA12-204C8B6A2701Q44029590-FA5E34FC-4DB9-493E-BB24-D09DBA928D2EQ44031175-EC348740-06A3-4707-858B-ED13A49F9591Q44549638-32FB764A-06E7-4E25-A6CD-68C2D929D349Q45002229-9F021575-A27C-4555-B87B-27358718B4EDQ53716911-755A6B96-B3EC-4AC5-9CD3-1D39537D1D16Q54058575-573CAD7D-19B5-4953-A844-2529D248F6AE
P2860
The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The global epidemiology of res ...... stance: a 10 year perspective.
@ast
The global epidemiology of res ...... stance: a 10 year perspective.
@en
type
label
The global epidemiology of res ...... stance: a 10 year perspective.
@ast
The global epidemiology of res ...... stance: a 10 year perspective.
@en
prefLabel
The global epidemiology of res ...... stance: a 10 year perspective.
@ast
The global epidemiology of res ...... stance: a 10 year perspective.
@en
P356
P1476
The global epidemiology of res ...... stance: a 10 year perspective.
@en
P2093
Thomson CJ
P356
10.1093/JAC/43.SUPPL_1.31
P407
P478
43 Suppl A
P577
1999-03-01T00:00:00Z